Search results
Results from the WOW.Com Content Network
GSK also said there remains no consistent or reliable evidence that ranitidine increases cancer risks. The False Claims Act lets whistleblowers sue on behalf of the federal government, and share ...
Some tests showed that Zantac's active ingredient, ranitidine, could degrade into NDMA over time or when exposed to heat. The U.S. Food and Drug Administration asked manufacturers to pull the drug ...
Ranitidine, previously sold under the brand name Zantac [a] among others, is a medication used to decrease stomach acid production. [12] It was commonly used in treatment of peptic ulcer disease, gastroesophageal reflux disease, and Zollinger–Ellison syndrome. [12] It can be given by mouth, injection into a muscle, or injection into a vein.
By Brendan Pierson (Reuters) -A Delaware judge has allowed more than 70,000 lawsuits over discontinued heartburn drug Zantac to go forward, ruling that expert witnesses can testify in court that ...
Ranitidine, a heartburn medicine sold under the brand name Zantac among others, was pulled from shelves in 2019, [1] following disclosure [2] of potential carcinogenic effects, [3] [4] which its manufacturers were accused of "engaging in a decades-long scheme to conceal." [5]
CHICAGO (Reuters) -A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands ...
First approved in 1983, Zantac became the world's best selling medicine in 1988 and one of the first-ever drugs to top $1 billion in annual sales. Originally marketed by a forerunner of GSK, it ...
Need to mention that it may cause false positive drug test for methamphetamine. ... Ranitidine is being used in emergency medicIne and in EMS for treatment of severe ...